Patient Care

Imprivata Patient Access Under Construction in Epic Toolbox for Identity Verification in MyChart

Integration will streamline and strengthen patient identification at all points of care, which improves PHI security, reduces duplicate medical records,…

4 months ago

scPharmaceuticals Receives Notice of Allowances of Multiple US Patent Applications Covering SCP-111

BURLINGTON, Mass., Aug. 14, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Company”), a pharmaceutical company committed to revolutionizing…

4 months ago

Analytics For Life Completes Clinical Study of Non-Invasive Point-of-Care Test for Elevated Pulmonary Capillary Wedge Pressure (PCWP) Using Machine Learning

Study achieves primary sensitivity endpoint, advancing diagnostics for heart failure with preserved ejection fraction (HFpEF) and pulmonary hypertension (PH)Results build…

4 months ago

OneMedNet Reports 80% Reduction in Debt Enabling Focus On Growth

MINNEAPOLIS, Aug. 14, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leader in…

4 months ago

Abeona Therapeutics® Reports Second Quarter 2025 Financial Results and Corporate Updates

- Received FDA approval for ZEVASKYN™ (prademagene zamikeracel), the first and only autologous cell-based gene therapy for the treatment of…

4 months ago

Alpha Global partners with LIO to redefine Mental Health Care in Australia

New platform boosts patient experience and safety, reduces clinician burden, and unlocks operational insight across inpatient mental health hospitals SYDNEY,…

4 months ago

DeepSight™ Technology Receives First FDA 510(k) Clearance for NeedleVue™ LC1 Ultrasound System

Bringing Clarity and Confidence to Ultrasound-Guided Interventional Procedures SANTA CLARA, Calif., Aug. 13, 2025 /PRNewswire/ -- DeepSight Technology, a medical…

4 months ago

Ultrasound AI Publishes Landmark Study Demonstrating Breakthrough in Predicting Delivery Timing Using AI and Ultrasound Images

AI-powered delivery date prediction model shows high accuracy and improved performance over time, with promise for global maternal health impact…

4 months ago

Ensysce Biosciences Reports Second Quarter 2025 Financial Results and Latest Program Updates

Initiates Critical Milestone, Launching Phase 3 Trial of PF614 to Advance Next-Generation Opioid Therapy Toward Regulatory ApprovalReceives $5.3 Million Installment…

4 months ago

Prochant Earns Fifth Straight Inc. 5000 Honor

156% 3-Year Growth, as AI-Driven Pulse Platform Scales in Home-Based Care RCM CHARLOTTE, N.C., Aug. 13, 2025 /PRNewswire/ -- Prochant,…

4 months ago